Dr. Nowshin Taslima Hossain has been working as a Junior Consultant at Ahsania Mission Cancer and General Hospital (AMCGH) since October 2022 to the present. Prior to this, she worked as a Resident Doctor at the National Institute of Cancer Research & Hospital (NICRH) from March 2017 to August 2022, and earlier served as an Honorary Medical Officer at the same institution from July 2015 to December 2015.

Local Publication:

• A Case Report on Triple Malignancy: Occurrence of Brain Tumor, Skin and Gastroesophageal Junction Carcinoma, Hossain NT, Arup MH
• Understanding Diagnostic Delays among Newly Diagnosed Breast Cancer Patients at a Tertiary Cancer Care Center in a Low-Middle-Income Country like Bangladesh Ferdause J, Hossain NT, Chowdhury AP, Ahmed N, Karim R, Momtahena SJ
• Early Age Breast Cancer: A Picture in Bangladesh Chowdhury AP, Hossain NT, Ferdause J, Momtahena SJ, Karim R, Ahmed N
• Prevalence of Triple Negative Subtypes among Breast Cancer Patients: An Institutional Study Karim R, Momtahena SJ, Ferdause J, Chowdhury AP, Hossain NT
• Determinants of Triple-Negative Breast Cancer: The Influence of Age and Contraceptive Use in Bangladesh Momtahena SJ, Ahmed N, Karim R, Ferdause J, Chowdhury AP, Hossain NT

International Publications:

• Hossain, N.T., Hussain, Q.M., Riad, A.H., Chowdhury, A.P., Ferdause, J. and Karim, R., 2024. Current practice pattern of postmastectomy hypo fractionated radiotherapy: A revolution in management. Radiotherapy and Oncology, 197, pp.S86-S87.
• Hossain, A., Galietta, E., Uddin, A.K., Zamfir, A.A., Hossain, N.T., Hossain, T., Hussain, Q.M., Morganti, A.G. and Bhuiyan, M.R., 2025. Efficacy and tolerability of single-fraction radiotherapy for spinal bone metastases in a low-middle-income country setting: a prospective study. Supportive Care in Cancer, 33(1), pp.1-7.
• Chowdhury, A.P., Khondakar, M.J., Hossain, N.T., Ferdause, J., Momtahena, S.J., Karim, R. and Hussain, Q.M., 2024. 337 From 15 to 5, adapting ultra hypo fractionated radiotherapy in Bangladesh: A single center study. Radiotherapy and Oncology, 197, pp.S84-S85.
• Ferdause, J., Momtahena, S.J., Karim, R., Chowdhury, A.P., Hossain, N.T., Islam, M.A., Habib, M.B., Kadir, A.S. and Haque, M.A., 2024. Trastuzumab‐induced toxic epidermal necrolysis in a Her‐2‐positive metastatic breast cancer patient—A rare case report. Clinical Case Reports, 12(7), p.e9103.

International Presentation:

• 2025-05: ESTRO 2025: Abstract accepted for presentation “Total neoadjuvant treatment (TNT) followed by surgery in locally advanced rectal cancer: Three years’ experience of Bangladeshi tertiary level hospital” at Vienna, Austria
• 2024-08: ESTRO Meets Asia 2024: Presentation on "Current practice pattern of postmastectomy hypo fractionated radiotherapy: A revolution in management" at Kuala Lumpur, Malaysia.
• 2023-10: FARO-KOSRO 2023, Presentation on Comparison between Hypo fractionated Versus Conventional Fractionated Radiotherapy in Locally Advanced Non-small Cell Lung Cancer at Seoul, South Korea (with travel grant)